Partial responders to intravenous corticosteroids at day 3 benefit from continued therapy in acute severe ulcerative colitis
Authors:
- Arshdeep SinghASArshdeep Singh
- Arshia BhardwajABArshia Bhardwaj
- Riya SharmaRSRiya Sharma
- Dharmatma SinghDSDharmatma Singh
- Devanshi JainDJDevanshi Jain
- Namita BansalNBNamita Bansal
- Shaji SebastianSSShaji Sebastian
- Laurent Peyrin-BirouletLPLaurent Peyrin-Biroulet
- Vandana MidhaVMVandana Midha
- Ajit SoodASAjit Sood
Open Access
- 30 April 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16
Abstract
In acute severe ulcerative colitis (ASUC), early response patterns to intravenous corticosteroids (IVCS) during the first week may shape subsequent disease course. Characterizing these trajectories is crucial for guiding timely therapy and improving patient outcomes. We evaluated response patterns to IVCS in hospitalized patients with ASUC. Clinical response was categorized as complete response (CR), partial response (PR), or non-response (NR) on days 3, 5, and 7. Patients were followed up to day 90 for need for rescue therapy (RT), post-discharge escalation of therapy (EOT), and mortality. Seventy-nine patients were analyzed. By day 3, 12 (15%) achieved CR, 34 (43%) PR, and 33 (42%) NR. Among the 67 patients with PR or NR on day 3, 9 (13.4%) achieved CR by day 5 and 22 (32.8%) more by day 7. On day 7, CR, PR, and NR were observed in 42 (53%), 17 (21%), and 20 (25%) patients, respectively. Patients with CR on day 3 had a lower, but not statistically significant, likelihood of needing RT + EOT by day 90 compared to NR (29% vs. 47%; p = 0.15). However, by day 5, patients with CR or PR had significantly lower day 90 RT + EOT needs compared to NR (26% vs. 54%, p = 0.02; 23% vs. 54%, p = 0.03). By day 7, the day 90 probability of RT + EOT was higher in PR (45%) and NR (63%) versus CR (16%) (p = 0.001 and < 0.0001, respectively). Only a small proportion of patients with ASUC show CR at day 3; most are partial responders. Partial responders to IVCS at day 3 frequently achieve CR by day 5–7, and have relatively favorable short term disease course, highlighting the prognostic value of early response stratification.Keywords
This publication has 19 references indexed in Scilit:
- Systematic review with meta‐analysis: mortality in acute severe ulcerative colitisAlimentary Pharmacology & Therapeutics, 2019
- Acute severe ulcerative colitis: from pathophysiology to clinical managementNature Reviews Gastroenterology & Hepatology, 2016
- Laboratory markers in ulcerative colitis: Current insights and future advancesWorld Journal of Gastrointestinal Pathophysiology, 2015
- ETHNIC VARIATION IN INTERLEUKIN-6 –174 (G/C) POLYMORPHISM IN THE MALAYSIAN POPULATIONBalkan Journal of Medical Genetics, 2013
- Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)Gut, 2011
- The pattern and outcome of acute severe colitisJournal of Crohn's and Colitis, 2010
- Ethnic differences in interleukin 6 (IL‐6) and IL6 receptor genes in spontaneous preterm birth and effects on amniotic fluid protein levelsAnnals of Human Genetics, 2007
- Outcome of a conservative approach in severe ulcerative colitisDigestive and Liver Disease, 2004
- Predicting outcome in severe ulcerative colitis.Gut, 1996
- Cortisone in Ulcerative ColitisBMJ, 1955